June 2006
Reactions Weekly;6/17/2006, Issue 1106, p18
Presents cases of bruising and ecchymosis after treatment with sibutramine for obesity. Daily dosage of sibutramine received by the patients.


Related Articles

  • SIBUTRAMINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p748 

    The article presents information on sibutramine, an appetite suppressant, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • sibutramine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p688 

    An encyclopedia entry for "sibutramine" is presented. It is a centrally acting appetite suppressant drug used to treat obesity in people who failed to respond to other methods of weight loss like dieting and exercise. Its common side effects include constipation, dry mouth and hypertension. It...

  • Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. Harrison-Woolrych, M.; Hill, G. R.; Clark, D. W. J. // International Journal of Obesity;Aug2006, Vol. 30 Issue 8, p1315 

    Objective:To determine whether postmarketing data provide evidence of an association of sibutramine with bruising.Design and patients:During a postmarketing surveillance study of sibutramine in New Zealand by the Intensive Medicines Monitoring Programme (IMMP), a series of reports of bruising...

  • APPETITE SUPPRESSANTS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p144 

    The article presents information on appetite suppresants, class of drugs used to suppress appetite to treat obesity, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • Sibutramine use in contraindicated conditions continues.  // Reactions Weekly;10/20/2007, Issue 1174, p3 

    This article states that Health Canada is receiving reports of cardiovascular adverse reactions associated with sibutramine use among patients who have contraindications. Health Canada has received 65 reports of such adverse reactions between January 2001 and May 2007. 13 of these reports...

  • Sibutramine overdose.  // Reactions Weekly;8/22/2009, Issue 1266, p29 

    The article describes the case of a girl who developed serotonin syndrome and rhabdomyolysis after accidentally ingesting an overdose of sibutramine. Thinking they were candies, she ingested about 27 pills of sibutramine. After several hours, she became agitated and experienced visual...

  • Physicians urged to observe the contraindications for sibutramine.  // Reactions Weekly;4/3/2004, Issue 995, p3 

    Deals with the call from the Swedish Medical Products Agency for physicians to observe the contraindications to sibutramine use. Contraindications experienced by patients to sibutramine use; Number of adverse reaction reports having a possible association with the drug received by the agency...

  • Health Canada issues warning against the use of Slim.  // Reactions Weekly;1/13/2007, Issue 1134, p3 

    This article reports that Health Canada warned consumers against the use of Slim, a weight-loss product manufactured in China. The warning comes after the health department of Hong Kong, China issued similar advice amongst concerns that the product is adulterated with sibutramine, a prescription...

  • appetite suppressants. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p66 

    An encyclopedia entry for "appetite suppressants" is presented. It refers to a group of drugs that reduce the desire to eat. This entry identifies sibutramine as the only commonly prescribed appetite suppressant. It also indicates the side effects of sibutramine, which include constipation, a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics